Cargando…

MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood. About 25% of RMS expresses fusion oncoproteins such as PAX3/PAX7-FOXO1 (fusion-positive, FP) while fusion-negative (FN)-RMS harbors RAS mutations. Radiotherapy (RT) plays a crucial role in local control but metastatic RMS is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cassandri, Matteo, Pomella, Silvia, Rossetti, Alessandra, Petragnano, Francesco, Milazzo, Luisa, Vulcano, Francesca, Camero, Simona, Codenotti, Silvia, Cicchetti, Francesca, Maggio, Roberto, Festuccia, Claudio, Gravina, Giovanni Luca, Fanzani, Alessandro, Megiorni, Francesca, Catanoso, Marialuigia, Marchese, Cinzia, Tombolini, Vincenzo, Locatelli, Franco, Rota, Rossella, Marampon, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508838/ https://www.ncbi.nlm.nih.gov/pubmed/34639012 http://dx.doi.org/10.3390/ijms221910671

Ejemplares similares

Radioresistance in rhabdomyosarcomas: Much more than a question of dose
por: Camero, Simona, et al.
Publicado: (2022)

Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2022)

The botanical drug PBI-05204, a supercritical CO(2) extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo
por: Vaccaro, Sara, et al.
Publicado: (2022)

Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization
por: Petragnano, Francesco, et al.
Publicado: (2020)

DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma
por: Camero, Simona, et al.
Publicado: (2021)

New Insights on the Nuclear Functions and Targeting of FAK in Cancer
por: Pomella, Silvia, et al.
Publicado: (2022)

DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma
por: Pomella, Silvia, et al.
Publicado: (2023)

Animal models of well-differentiated/dedifferentiated liposarcoma: utility and limitations
por: Codenotti, Silvia, et al.
Publicado: (2019)

Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation
por: Perrone, Clara, et al.
Publicado: (2023)

Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines In Vitro and In Vivo
por: Colapietro, Alessandro, et al.
Publicado: (2020)

Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
por: Ciccarelli, Carmela, et al.
Publicado: (2016)

Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
por: Megiorni, Francesca, et al.
Publicado: (2017)

Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results
por: De Felice, Francesca, et al.
Publicado: (2016)

OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence
por: Megiorni, Francesca, et al.
Publicado: (2021)

Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
por: Gravina, Giovanni L, et al.
Publicado: (2010)

Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors
por: Codenotti, Silvia, et al.
Publicado: (2022)

Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and Heterodimers
por: Maggio, Roberto, et al.
Publicado: (2021)

A ‘click’ chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras
por: Cross, Jasmine M., et al.
Publicado: (2022)

PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines
por: Camero, Simona, et al.
Publicado: (2018)

Essential Amino Acids-Rich Diet Decreased Adipose Tissue Storage in Adult Mice: A Preliminary Histopathological Study
por: Corsetti, Giovanni, et al.
Publicado: (2022)

Radiation therapy and serum salivary amylase in head and neck cancer
por: De Felice, Francesca, et al.
Publicado: (2017)

Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics
por: Fasciani, Irene, et al.
Publicado: (2020)

FAK Signaling in Rhabdomyosarcoma
por: Perrone, Clara, et al.
Publicado: (2020)

Defective DNA repair mechanisms in prostate cancer: impact of olaparib
por: De Felice, Francesca, et al.
Publicado: (2017)

Unraveling the Functional Significance of Unstructured Regions in G Protein-Coupled Receptors
por: Maggio, Roberto, et al.
Publicado: (2023)

DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation
por: Megiorni, Francesca, et al.
Publicado: (2016)

Anti-oncogenic and pro-myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma
por: Di Rocco, Agnese, et al.
Publicado: (2022)

Revisiting entinostat as an immune-potentiating adjuvant
por: McCaw, Tyler R., et al.
Publicado: (2018)

Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2019)

The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
por: Festuccia, Claudio, et al.
Publicado: (2018)

CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas
por: Cassandri, Matteo, et al.
Publicado: (2020)

Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage
por: Marampon, Francesco, et al.
Publicado: (2015)

The CRISP(Y) Future of Pediatric Soft Tissue Sarcomas
por: Pomella, Silvia, et al.
Publicado: (2020)

Correction: Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage
por: Marampon, Francesco, et al.
Publicado: (2016)

Targeting SALL4 by entinostat in lung cancer
por: Yong, Kol Jia, et al.
Publicado: (2016)

Entinostat-Bortezomib Hybrids against Multiple Myeloma
por: Ferro, Angelica, et al.
Publicado: (2023)

Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
por: Festuccia, C., et al.
Publicado: (2018)

Treatment of Solitary Painful Osseous Metastases with Radiotherapy, Cryoablation or Combined Therapy: Propensity Matching Analysis in 175 Patients
por: Di Staso, Mario, et al.
Publicado: (2015)

MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression
por: Perrone, Clara, et al.
Publicado: (2022)

Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications
por: Sideri, Silvia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_93c058fuh1o7s97kj7cadueao7